Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors' reply.
Saved in:
| Title: | Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors' reply. |
|---|---|
| Authors: | Narula, N.1 neeraj.narula@medportal.ca, Reinisch, W.1,2 |
| Source: | Alimentary Pharmacology & Therapeutics. Oct2016, Vol. 44 Issue 7, p772-773. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
